RESMED INCInsider Trading & SEC Form 4 Analysis
Institutional analysis of internal capital flows based on SEC Form 4 filings.
-$34.4M
Buys minus sales2026.07.07
Latest Form 414
Reporting entitiesNo buyer detected
No open-market buysFarrell Michael J.
$2.3MAutomated_Intelligence_Report :: RMD
Algorithmic analysis of recent insider trading activity for RMD reveals a bearish posture among the C-suite and board members. Based on the latest SEC Form 4 filings, we have tracked capital events executed by 14 distinct corporate insiders. The aggregate nominal exposure during this reporting cycle reached $52.12M.
Market dynamics show a negative net capital flow of $34.41M when isolating open-market purchases versus open-market sales. The trading volume is heavily weighted towards open-market executions, providing a clearer signal of insider conviction regarding current valuation levels compared to option-based equity grants.
From a microstructural perspective, the most significant liquidity event was a divestment by Farrell Michael J. (Officer/Other), which accounts for a major share of the recent outflow. Continuous monitoring of these Tier-1 actors is essential, as their liquidity decisions often precede material corporate events or reflect an informed, asymmetric perspective on the future performance of RMD.
$52.12M
USD NOMINAL VALUE14
UNIQUE C-SUITE ENTITIES2026.07.07
ISO_8601 FORMATAutomated_Queries :: Frequently Asked Questions
>Is insider buying outweighing selling at RMD?
Open-market selling volume ($34.41M) currently exceeds buying volume ($0.00M), indicating net liquidation by insiders.
>Who is currently buying RMD stock?
Our algorithmic tracking of SEC Form 4 filings indicates no significant open-market buying activity by major executives for RMD in the recent reporting period.
>Are RMD insiders selling their shares?
Yes, we have tracked $34.41M in recent insider liquidations. The most notable recent seller is Farrell Michael J., who executed the largest single offload.